Development, Standardization, Organoleptic Evaluation, and Nutritional intervention of Pearl Millet and Sorghum Millet-Based Recipes in Patients with Dyslipidemia

Document Type : Original Article

Authors

1 Department of Home Science, Guru Nanak Girls College, Yamuna Nagar, India

2 Department of Home Science, Kurukshetra University, Kurukshetra, India

10.30476/ijns.2025.106402.1443

Abstract

Background: Degraded low-density lipoproteins (LDL), very lowdensity lipoprotein (VLDL), Intermediate-density lipoprotein (IDL) and high-density lipoproteins (HDL) cholesterol can cause dyslipidemia. The present study was conducted to determine the viability of augmented millet-based recipes and to observe the biochemical impact of these recipes on dyslipidemic subjects.
Methods: An augmented mixture of chia seeds, walnuts, and mango seed powder was developed and incorporated at different levels into milletbased recipes. Developed millet recipes were administered to dyslipidemic subjects for the duration of three months and their biochemical impacts were assessed.
Results: The augmented millet-based recipes had balanced energy content and a high proportion of proteins, dietary fiber, monounsaturated fatty acids, and linoleic acid. Administration of these millet-based recipes to dyslipidemic subjects could significantly improve the lipid profile of patients. The developed and augmented millet-based recipes showed significant improvements in all nutritive values too.
Conclusion: Intervention of these recipes for the duration of three months was shown to improve the modified lipid profile.

Keywords

References

  1. Stroke manual. Dyslipidemia (2023). https://www.stroke-manual.com/dyslipidemia/?page=2
  2. Sarah D, Ferranti -Jane, Newburger JW (2023). Dyslipidemia in children and adolescents: Definition, screening, and diagnosis. https://www.uptodate.com/contents/dyslipidemia-in-children-and-adolescnets-defination-screening-and-diagnosis#disclaimerConten
  3. Liu X, Yu S, Mao Z, Li Y, Zhang H, Yang K, Zhang H, Liu R, Qian X, Li L, Bie R, Wang C. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan Rural Cohort Study, Lipids Health Dis 2018;17:119. DOI: 10.1186/s12944-018-0768-7. PMID: 29788966.
  4. Nirwan R, Singh D. Distribution of Lipids and Prevalence of Dyslipidemia among Indian Expatriates in Qatar, J Lipids. 2021:2021:8866784. DOI: 10.1155/2021/8866784. PMID: 33747568.
  5. Rani RJ, Deepa P, Shanthi R. Prevalence of atherogenic dyslipidemia in young asymptomatic medical professionals of a Tertiary Care Hospital in South India: A cross-sectional study. Int J Clin Biochem Res. 2020;7:403-407. DOI:10.18231/j.ijcbr.2020.086.
  6. Rabiee MR, Tahmasebi R, Koushkie M, et al. The Effect of Mediterranean Diet and High-Intensity Interval Training on Lipid Profile and HbA1c Level among Overweight and Obese Female Population. Int J Nutr Sci. 2024;9:132-138. DOI: 10.30476/IJNS.2024.100044.1263.
  7. Soltani M, Gerami S, Ghaem Far Z, et al. Higher Glycemic Index and Load Could Increase Risk of Dyslipidemia. Int J Nutr Sci. 2023;8:150-157. DOI: 10.30476/ IJNS.2023.97742.1219.
  8. Hedayatnia M, Asadi Z, Zare-Feyzabadi R, et al. Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Lipids Health Dis. 2020;19,42. DOI: 10.1186/s12944-020-01204-y. PMID: 32178672.
  9. Cicero AFG, Fogacci F, Stoian AP, et al. Nutraceuticals in the management of dyslipidemia: which, when and for whom? Could Nutraceuticals help low risk individuals with non-optimal lipid levels? Curr Atheroscler Rep. 2021;23:57. DOI: 10.1007/s11883-021-00955-y. PMID: 34345932.
  10. Aghasadeghi K, Zarei-Nezhad M, Keshavarzi A, et al. The prevalence of coronary risk factors in Iranian lor migrating tribe. Arch Iran Med. 2008;11:322-5. PMID: 18426325.
  11. Sabuz AA, Rana MR, Ahmed T, et al. Health- promoting potential of millet: a review. Separations. 2023;10:80. DOI: 3390/separations10020080.
  12. Alzahrani NS, Alshammari GM, El-Ansary A, et al. Grains and their Ethanol Extract on rats fed a high fat diet, 2022;14:1791. DOI: 10.3390/nu14091791. PMID: 35565759.
  13. Anitha A, Botha R, Kane-Potaka J, et al. Can millet consumption help manage hyperlipidemia and obesity? :Systematic review and meta analysis. Front Nutr. 2021;8:700778. DOI: 10.3389/fnut.2021.700778. PMID: 34485362.
  14. Vedamanickman R, Anandan P, Bupesh S, et al. Study of millet and non millet diet on diabetic and associated metabolic syndrome. Biomed: Int J Biomed Sci. 2020;40.
  15. Ambati K, Sucharitha KV. Millets review on nutritional profiles and health benefits. Int J Recent Sci Res. 2019;10:3393-33948.
  16. Silva LdeA, Verneque BJF, Mota APL, et al. Chia seed (Salvia hispanica L.) consumption and lipid profile: systematic review and meta analysis. Food Func. 2021;12:8835. DOI: 10.1039/d1fo01287h. PMID: 34378609.
  17. Tamargo A, Martin D, Hierro JND, et al. Intake of soluble fiber from chia seed reduces bioaccessibility of lipids, cholesterol and glucose in the dynamic gastrointestinal model simgi. Food Res Int. 2020;137:109364. DOI: 10.1016/j.foodres.2020.109364. PMID: 33233067.
  18. Aremu MO, Awagulu MS, Ayakeme EB, et al. Lipid profile and health attributes of mango (Mangifera indica L.) seed kernel and cashew (Anacardium occidentale L.) nut kernel: a comparative study. J Hum Health Halal Metr. 2022;3:14-22. DOI: 10.30502/jhhhm.2022.364887.1061.
  19. Masud F, Rifai A, Sayuti M, et al. Mango seed kernel flour (Mnagifera indica): nutrient composition and potential as food. Malaysian J Nutr. 2020;26:101-106.
  20. Alshahrani SM, Mashat RM, Almutairi D, et al. The effect of walnut intake on lipids: a systematic review and meta analysis of randomized controlled trial. 20222;14:4460.  DOI: 10.3390/nu14214460. PMID: 36364723.
  21. Shivakumar C.S, Satish A, Devi U, et al. The impact of daily walnuts consumption and lifestyle changes on dyslipidmemia. Food Sci Nutr. 2022;
  22. Kalash P, Tewari P, Kachhawaha S, et al. Organoleptic and nutritional evaluation of pearl millet (bio- fortified, value added products). Annals of Arid zone. 2023;62:155-59. DOI:10.59512/aaz.2023.62.2.9.
  23. Kalange ND, Chavan UD, Godase SN, et al . Studies on organoleptic properties of papad prepared from different cultivator of pearl millet. Int J Curr Microbiol Appl Sci. 2020;11:4072-4080. 
  24. Mehra A, Singh U. Development, organoleptic and nutritional evaluation of pearl millet based mathri. Int J Rec Sci Res. 2017;8:17939-17942.
  25. Afify AEM, El-Beltagi HS, El-Salam SMA, et al. Effect of soaking, cooking, germination and fermentation processing on physical properties and sensory evaluation of sorghum biscuits. Notulae Sci Biologic. 2015;7:129-135. DOI: 10.15835/nsb719428.
  26. Chavan UD, Pansare SS, Patil JV, et al. Preparation and nutritional quality of sorghum papads. Int J Curr Microbiol Appl Sci. 2015;4:806-823.
  27. Noerhartati E, Wedowati ER, Puspitasari D, et al. Analysis characteristics organoleptic of sorghum pie for quality entrepreneurial products with the influence of varieties and concentration of flour. Proceedings of the International Conference on Industrial Engineering and Operations Management Pilsen, July 23-26, 2019.
  28. Mishra P, Prakash HG, Devi S, et al. Nutritional quality of millets and their value added products with the potential health benefits; a review. Int J Curr Microbiol Appl Sci. 2021;10:163-175.
  29. Rao BD, Kandlakunta B, Christina A, et al. Nutritional and health benefits of millets. Nutritional and Health Benefits of Millets. ICAR – INDIAN INSTITUTE OF MILLETS RESEARCH (IIMR) 2017.
  30. Porwal A, Bhagwat G, Sawarkar J, et al. An overview of millets- the nutria cereals: Its nutritional profile, potential health benefits and sustainable cultivation approach. Int J Sci Res Arch. 2023;10:841-859. DOI:10.30574/ijsra.2023.10.1.0828.
  31. Bhatt D, Fairos M, Mazumdar A. Millets: Nutritional composition, production and significance: A Pharma Innovat J. 2022;SP-11:1577-1582.
  32. Singh RB, Fedacko J, Mojto V, et al. Effects of millet based functional foods rich diet on coronary risk factors among subjects with diabetes mellitus: a single arm real world observation from hospital registry. Public Health. 2020;9:18-25.
  33. Jali MV, Kamatar MY, Jali SM, et al. Efficacy of value added foxtail millet therapeutic food in the management of diabetes and dyslipidemia in type 2 diabetic patients. Recent Res Sci Technol.  2012;4:3-4.
  34. Zhao L, Chen W, Hu Y. Impact of whole-grain millet consumption on lipid metabolism and inflammatory biomarkers among overweight adults: A randomized controlled trial. J Nutr Func Foods. 2025;18:45-56. DOI: 1039/D5FO03240G.
  35. Martínez-García P, Santos R, Oliveira M. Advances in dietary management of dyslipidemia: Role of high-fiber cereals and plant-based diets. Curr Atheroscler Rev. 2025;21:112-128.
  36. Kumar S, Patel A, Reddy R. Sensory and nutritional evaluation of bio-fortified pearl millet–based functional foods. Int J Food Sci Nutr Res.2025;14:78-89.
  37. Al-Shammari F, Al-Mansour R, Al-Harbi N . Effect of functional millet foods on serum lipid profile in pre-diabetic individuals: A 16-week intervention study. Clin Nutr Insights. 2025;5:130-142.
  38. Nguyen T, Park J, Lee S. Nutritional enhancement and consumer acceptability of millet-enriched traditional Asian recipes. Food Sci Human Wellness. 2025;14:250-262.
  39. Sharma P, Nambiar V, Thomas J. Comparative evaluation of sorghum and pearl millet-based therapeutic diets in dyslipidemic adults. J Diet Human Metab. 2025;9: 23-35.
  40. Harris M, O’Connor L, Wolfe T. Dietary fibers and MUFA-rich grains in the regulation of cholesterol: A systematic review and meta-analysis. Nutr Metab Adv. 2025;4:1-18.
International Journal of Nutrition Sciences
Volume 10, Issue 4 - Serial Number 4
December 2025
Pages 647-657

Files

Share

How to cite

Statistics